BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11011015)

  • 1. Ovarian steroids influence the activity of neuroendocrine dopaminergic neurons.
    DeMaria JE; Livingstone JD; Freeman ME
    Brain Res; 2000 Oct; 879(1-2):139-47. PubMed ID: 11011015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Hydroxyestradiol is not mediating the effects of estradiol on tuberoinfundibular dopaminergic neurons controlling prolactin secretion in female rats.
    Fernández-Ruiz JJ; Alvarez-Sanz C; Ramos JA
    J Steroid Biochem; 1989 Jan; 32(1A):71-5. PubMed ID: 2536446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of low hypothalamic dopaminergic activity after removal of chronic estrogen treatment.
    Gottschall PE; Sarkar DK; Meites J
    Proc Soc Exp Biol Med; 1986 Jan; 181(1):78-86. PubMed ID: 3945627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage.
    Morel GR; Carón RW; Cónsole GM; Soaje M; Sosa YE; Rodríguez SS; Jahn GA; Goya RG
    Brain Res Bull; 2009 Dec; 80(6):347-52. PubMed ID: 19744546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen fails to reduce tuberoinfundibular dopaminergic neuronal activity and to cause a prolactin surge in lactating, ovariectomized rats.
    Higuchi T; Honda K; Takano S; Negoro H
    Brain Res; 1992 Mar; 576(1):143-6. PubMed ID: 1515907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocryptine prevents the decline in tuberoinfundibular neuronal release of dopamine after removal of chronic estrogen treatment.
    Gottschall PE; Meites J
    Proc Soc Exp Biol Med; 1987 Nov; 186(2):150-6. PubMed ID: 3671354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that prolactin mediates the stimulatory effects of estrogen on tuberoinfundibular dopamine neurons in female rats.
    Toney TW; Pawsat DE; Fleckenstein AE; Lookingland KJ; Moore KE
    Neuroendocrinology; 1992 Mar; 55(3):282-9. PubMed ID: 1323801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in tuberoinfundibular dopaminergic neuron activity during the rat estrous cycle in relation to the prolactin surge: alteration by a mammary carcinogen.
    Pasqualini C; Bojda F; Gaudoux F; Guibert B; Leviel V; Teissier E; Rips R; Kerdelhue B
    Neuroendocrinology; 1988 Sep; 48(3):320-7. PubMed ID: 2903462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a permanent decline in tuberoinfundibular dopaminergic neuronal function after chronic estrogen treatment is terminated in Fischer 344 rats.
    Gottschall PE; Meites J
    Neuroendocrinology; 1986; 44(2):211-6. PubMed ID: 3796794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
    Pilotte NS; Burt DR; Barraclough CA
    Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin-induced activation of hypothalamic dopaminergic neurons is accompanied by a decrease in pituitary secretion of prolactin and alpha-melanocyte-stimulating hormone.
    Pan JT; Tian Y; Lookingland KJ; Moore KE
    Life Sci; 1992; 50(25):2011-7. PubMed ID: 1593929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-induced suppression of the prolactin afternoon surge in ovariectomized, estrogen-treated rats and the nocturnal surge in pseudopregnant rats are accompanied by an increase in median eminence dihydroxyphenylacetic acid concentrations.
    Morehead MH; Lookingland KJ; Gala RR
    Neuroendocrinology; 1990 Feb; 51(2):208-12. PubMed ID: 2106099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of anandamide on prolactin secretion is modulated by estrogen.
    Scorticati C; Mohn C; De Laurentiis A; Vissio P; Fernández Solari J; Seilicovich A; McCann SM; Rettori V
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2134-9. PubMed ID: 12578974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
    Murai I; Garris PA; Ben-Jonathan N
    Endocrinology; 1989 May; 124(5):2343-9. PubMed ID: 2495929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preovulatory prolactin surge is prolonged by a progesterone-dependent dopaminergic mechanism.
    Arbogast LA; Ben-Jonathan N
    Endocrinology; 1990 Jan; 126(1):246-52. PubMed ID: 1967162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The secretory activity of the tuberoinfundibular dopaminergic neurons is modulated by the thyroid status in the adult rat: consequence on prolactin secretion.
    Reymond MJ; Benotto W; Lemarchand-Béraud T
    Neuroendocrinology; 1987 Jun; 46(1):62-8. PubMed ID: 3112600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapid 'tonic' and the delayed 'induction' components of the prolactin-induced activation of tuberoinfundibular dopaminergic neurons following the systemic administration of prolactin.
    Demarest KT; Riegle GD; Moore KE
    Neuroendocrinology; 1986; 43(3):291-9. PubMed ID: 3090463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of electrical stimulation of the ventromedial nucleus and the dorsomedial nucleus on the activity of tuberoinfundibular dopaminergic neurons.
    Gunnet JW; Moore KE
    Neuroendocrinology; 1988 Jan; 47(1):20-6. PubMed ID: 3124013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of tuberohypophysial dopaminergic neurons terminating in the intermediate lobe and in the neural lobe of the rat pituitary gland.
    Lookingland KJ; Farah JM; Lovell KL; Moore KE
    Neuroendocrinology; 1985 Feb; 40(2):145-51. PubMed ID: 3156283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.